Concepedia

Publication | Open Access

JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial

DOIFull Paper Access

266

Citations

38

References

2017

Year

Katherine R. Tuttle, Frank C. Brosius, Sharon G. Adler, Matthias Kretzler, Ravindra L. Mehta, James A. Tumlin, Yoshiya Tanaka, Masakazu Haneda, Jiajun Liu, Maria Silk,
Nephrology Dialysis Transplantation

Abstract

Baricitinib decreased albuminuria in participants with Type 2 diabetes and DKD. Further research is required to determine if baricitinib reduces DKD progression.

References

YearCitations

Page 1